West G. L., Drisdelle B. L., Konishi K., Jackson J., Jolicoeur P., Bohbot V. (2015). Habitual action video game playing is associated with caudate nucleus-dependent navigational strategies, Proc Biol Sci, 282(1808), 20142952. En savoir plus.

Wheeler A. L., Wessa M., Szeszko P. R., Foussias G., Chakravarty M., Lerch J. P., DeRosse P., Remington G., Mulsant B. H., Linke J., Malhotra A. K., Voineskos A. N. (2015). Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis, JAMA Psychiatry, 72(5), 446-55. En savoir plus.

Xiao Y., Fonov V., Beriault S., Subaie F. A., Chakravarty M., Sadikot A. F., Pike G. B., Collins D. L. (2015). Multi-contrast unbiased MRI atlas of a Parkinson's disease population, Int J Comput Assist Radiol Surg, 10(3), 329-341. En savoir plus.

Yushkevich P. A., Amaral R. S., Augustinack J. C., Bender A. R., Bernstein J. D., Boccardi M., Bocchetta M., Burggren A. C., Carr V. A., Chakravarty M., Chetelat G., Daugherty A. M., Davachi L., Ding S. L., Ekstrom A., Geerlings M. I., Hassan A., Huang Y., Iglesias J. E., La Joie R., Kerchner G. A., LaRocque K. F., Libby L. A., Malykhin N., Mueller S. G., Olsen R. K., Palombo D. J., Parekh M. B., Pluta J. B., Preston A. R., Pruessner J., Ranganath C., Raz N., Schlichting M. L., Schoemaker D., Singh S., Stark C. E., Suthana N., Tompary A., Turowski M. M., Van Leemput K., Wagner A. D., Wang L., Winterburn J. L., Wisse L. E., Yassa M. A., Zeineh M. M. (2015). Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol, Neuroimage, 111, 526-41. En savoir plus.

Adamantidis A., Zhang F., de Lecea L., Deisseroth K. (2014). Establishing a fiber-optic-based optical neural interface, Cold Spring Harb Protoc, 2014(8), 839-44. En savoir plus.

Adamantidis A., Zhang F., de Lecea L., Deisseroth K. (2014). Optogenetics: opsins and optical interfaces in neuroscience, Cold Spring Harb Protoc, 2014(8), 815-22. En savoir plus.

Bastianetto S., Menard C., Quirion R. (2014). Neuroprotective action of resveratrol, Biochim Biophys Acta. En savoir plus.

Belleville S., Gauthier S., Lepage E., Kergoat M. J., Gilbert B. (2014). Predicting decline in mild cognitive impairment: a prospective cognitive study, Neuropsychology, 28(4), 643-52. En savoir plus.

Boccardi M., Bocchetta M., Apostolova L. G., Barnes J., Bartzokis G., Corbetta G., DeCarli C., deToledo-Morrell L., Firbank M., Ganzola R., Gerritsen L., Henneman W., Killiany R. J., Malykhin N., Pasqualetti P., Pruessner J., Redolfi A., Robitaille N., Soininen H., Tolomeo D., Wang L., Watson C., Wolf H., Duvernoy H., Duchesne S., Jack C. R., Frisoni G. B. (2014). Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance, Alzheimers Dement. En savoir plus.

Bocchetta M., Boccardi M., Ganzola R., Apostolova L. G., Preboske G., Wolf D., Ferrari C., Pasqualetti P., Robitaille N., Duchesne S., Jack C. R., Frisoni G. B., Pruessner J. (2014). Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project, Alzheimers Dement. En savoir plus.

Breitner J. (2014). Mild cognitive impairment and progression to dementia: new findings, Neurology, 82(4), e34-5. En savoir plus.

Breitner J. (2014). What should we do if we were wrong and Alzheimer was right?, Int Psychogeriatr, 1-4. En savoir plus.

Breitner J. (2014). Observations on DSM-5 Mild Neurocognitive Disorder vs. its predecessor, Mild Cognitive Impairment, Acta Psychiatr Scand. En savoir plus.

Chuang Y. F., Breitner J., Chiu Y. L., Khachaturian A., Hayden K., Corcoran C., Tschanz J., Norton M., Munger R., Welsh-Bohmer K., Zandi P. P., Cache County Investigators (2014). Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study, Neurobiol Aging, 35(11), 2429-35. En savoir plus.

Cyr M., Parent M. J., Mechawar N., Rosa-Neto P., Soucy J. P., Aliaga A., Kostikov A., Maclaren D. A., Clark S. D., Bedard M. A. (2014). PET imaging with [(1)(8)F]fluoroethoxybenzovesamicol ([(1)(8)F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat, Nucl Med Biol, 41(1), 96-101. En savoir plus.

Cyr M., Parent M. J., Mechawar N., Rosa-Neto P., Soucy J. P., Clark S. D., Aghourian M., Bedard M. A. (2014). Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [F]fluoroethoxybenzovesamicol, Behav Brain Res, 278C, 107-114. En savoir plus.

De Schutter J. W., Park J., Leung C. Y., Gormley P., Lin Y. S., Hu Z., Berghuis A. M., Poirier J., Tsantrizos Y. S. (2014). Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases, J Med Chem, 57(13), 5764-76. En savoir plus.

Dedovic K., Duchesne A., Engert V., Lue S. D., Andrews J., Efanov S. I., Beaudry T., Pruessner J. (2014). Psychological, endocrine and neural responses to social evaluation in subclinical depression, Soc Cogn Affect Neurosci, 9(10), 1632-44. En savoir plus.

Dubois B., Feldman H. H., Jacova C., Hampel H., Molinuevo J. L., Blennow K., DeKosky S. T., Gauthier S., Selkoe D., Bateman R., Cappa S., Crutch S., Engelborghs S., Frisoni G. B., Fox N. C., Galasko D., Habert M. O., Jicha G. A., Nordberg A., Pasquier F., Rabinovici G., Robert P., Rowe C., Salloway S., Sarazin M., Epelbaum S., de Souza L. C., Vellas B., Visser P. J., Schneider L., Stern Y., Scheltens P., Cummings J. L. (2014). Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, 13(6), 614-29. En savoir plus.

Duerden E. G., Card D., Roberts S. W., Mak-Fan K. M., Chakravarty M., Lerch J. P., Taylor M. J. (2014). Self-injurious behaviours are associated with alterations in the somatosensory system in children with autism spectrum disorder, Brain Struct Funct, 219(4), 1251-61. En savoir plus.